dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 766139000

Production

Component

The component that hold information about this concept.

Fully Specified Name (FSN)

Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)

Shortest Term

Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial

Definition Status

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Summary

Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)

SCTID: 766139000, Defined, Active

766139000|Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)|

en Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial
en Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)

Expression

766139000 |Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)|
 === 385224003 |Powder for conventional release suspension for injection (dose form)| + 
733026001 |Vial (unit of presentation)| + 
779655006 |Product containing only lanreotide in parenteral dose form (medicinal product form)| : 
        { 732943007 |Has basis of strength substance (attribute)| = 395765000 |Lanreotide (substance)|,
762949000 |Has precise active ingredient (attribute)| = 429611006 |Lanreotide acetate (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 733026001 |Vial (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        

Diagram

Active

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
3689780015 - Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (en) View
3689780015	en	Synonym (core metadata concept)	Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Acceptable	False
3689778014 - Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial (en) View
3689778014	en	Synonym (core metadata concept)	Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
3689779018 - Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug) (en) View
3689779018	en	Fully specified name (core metadata concept)	Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (9488235021) - 766139000 -> 38112003 (732946004) View
732946004 \|Has presentation strength denominator value (attribute)\|	38112003 \|1 (qualifier value)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (9488239026) - 766139000 -> 732658001 (732944001) View
732944001 \|Has presentation strength numerator value (attribute)\|	732658001 \|30 (qualifier value)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (9488241025) - 766139000 -> 38112003 (766952006) View
766952006 \|Count of base of active ingredient (attribute)\|	38112003 \|1 (qualifier value)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (9283544022) - 766139000 -> 440132002 (116680003) View
116680003 \|Is a (attribute)\|	440132002 \|Product manufactured as parenteral dosage form (product)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (9283545023) - 766139000 -> 327379003 (116680003) View
116680003 \|Is a (attribute)\|	327379003 \|Lanreotide (product)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (10721776029) - 766139000 -> 779655006 (116680003) View
116680003 \|Is a (attribute)\|	779655006 \|Product containing only lanreotide in parenteral dose form (medicinal product form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9283546024) - 766139000 -> 385224003 (411116001) View
411116001 \|Has dose form (attribute)\|	385224003 \|Powder for conventional release suspension for injection (dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9488234020) - 766139000 -> 733026001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	733026001 \|Vial (unit of presentation)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9488236022) - 766139000 -> 733026001 (763032000) View
763032000 \|Has unit of presentation (attribute)\|	733026001 \|Vial (unit of presentation)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9488237029) - 766139000 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9488238023) - 766139000 -> 395765000 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	395765000 \|Lanreotide (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9488240029) - 766139000 -> 429611006 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	429611006 \|Lanreotide acetate (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
385224003 View
385224003	Powder for conventional release suspension for injection (dose form)	Powder for injection suspension	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
779655006 View
779655006	Product containing only lanreotide in parenteral dose form (medicinal product form)	Lanreotide only product in parenteral dose form	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
733026001 View
733026001	Vial (unit of presentation)	Vial	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Terminology chevron_right Concepts chevron_right 766139000

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches